RCT | Telmisartan did not improve walking performance in patients with lower extremity peripheral artery disease.

Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Telmisartan and Walking Performance in Peripheral Artery Disease – JAMA (free for a limited period)

Audio interview: Treatment of Peripheral Artery Disease – JAMA

Commentary on Twitter

Study results do not support #telmisartan for improving walking performance in patients with lower extremity #PeripheralArteryDisease https://t.co/QErZh3i3rO pic.twitter.com/nhthGoIQym

— JAMA (@JAMA_current) October 5, 2022